SHORT_NAME	LONG_NAME	ABSTRACT	CANCER_SITE	PATIENT_ID_NAME	INTEGRATED	OVERALL_ACCESS	SCHEMA_NAME	USE_IN_GUI	CONTENT_TYPES	SHOW_CONTENT_IN_GUI
BRC_LOI_2008_03	Molecular profiling with ER and tamoxifen status . 	Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen. Sherene Loi, Benjamin Haibe-Kains, Christine Desmedt, Pratyaksha Wirapati, Françoise Lallemand, Andrew M Tutt, Cheryl Gillet, Paul Ellis, Kenneth Ryder, James F Reid, Maria G Daidone,Marco A Pierotti, Els MJJ Berns, Maurice PHM Jansen, John A Foekens, Mauro Delorenzi, Gianluca Bontempi, Martine J Piccart and Christos Sotiriou. BMC Genomics 2008, 9:239 <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE6532">http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE6532</a>; <a href="http://www.ncbi.nlm.nih.gov/pubmed/18498629">http://www.ncbi.nlm.nih.gov/pubmed/18498629</a>	BREAST	Sample iid	1	PRIVATE	BRC_LOI_2008_03	1	CLINIC, MICROARRAY	1, 1
